Biotech Review - Waiting For A Reset

Let's talk S&P Biotechnology stocks. The core position is long, but another opportunity may be coming.


Disclaimer: Content provided by Eric De Groot is intended as general information and not specific recommendations. Individuals are responsible for their own investment decisions. Past ...

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.
Dick Kaplan 1 week ago Member's comment

Good analysis. However, you missed the hourly chart. The biotech correction on the daily is possibly over. Why? Because the daily averages crossed and point upward on hourly chart. Talking daily, the current candle is perfectly sitting on the trend line support and between the 10sma and 30 ema with $XBI on a intact uptrend. So all stars seem aligned for the XBI to resume in a upward channel.

Harry Sinclair 1 week ago Member's comment

True, but remember that anything can happen again in the stock market. You do your due diligence but in the end it is closer to a casino than a market 😂